Cupps Capital Management’s Edwards Lifesciences EW Stock Holding History

Cupps Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.8M	Sell	69,681 -121,311	-64%	-$4.57M	1.21%	17
2016 Q2	$6.35M	Buy	190,992 +3,264	+2%	+$112K	1.64%	9
2016 Q1	$5.52M	Sell	187,728 -148,749	-44%	-$4.1M	1.05%	21
2015 Q4	$8.86M	Sell	336,477 -152,037	-31%	-$3.95M	1.24%	24
2015 Q3	$11.6M	Buy	488,514 +177,204	+57%	+$4.28M	1.54%	16
2015 Q2	$7.39M	Buy	311,310 +91,248	+41%	+$2.06M	0.71%	56
2015 Q1	$5.22M	Buy	220,062 +83,292	+61%	+$1.87M	0.46%	79
2014 Q4	$2.9M	Buy	136,770 +39,666	+41%	+$797K	0.26%	101
2014 Q3	$1.65M	Buy	+97,104	New	+$1.53M	0.15%	122

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cupps Capital Management's EW Position: Q3 2016 in Review

Cupps Capital Management reduced its Edwards Lifesciences (EW) stake by 64% in Q3 2016, selling an estimated $4.57M and leaving 69,681 shares worth $2.8M. The position accounts for 1.21% of the portfolio, ranked #17.

Cupps Capital Management first reported a position in EW in Q3 2014 and has held it in 9 quarters since. The position peaked at $11.6M in Q3 2015. 694 funds tracked by Wall St. Rank hold EW as of Q3 2016.

Cupps Capital Management held 69,681 shares of Edwards Lifesciences worth $2.8M as of Q3 2016.
Cupps Capital Management sold 121,311 Edwards Lifesciences shares in Q3 2016, an estimated $4.57M.
Edwards Lifesciences made up 1.21% of Cupps Capital Management's portfolio in Q3 2016, its #17 holding.
Cupps Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 9 quarters since.
Cupps Capital Management's Edwards Lifesciences position peaked at $11.6M in Q3 2015.
694 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.